| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/30/2013 | CN102906266A Universal dengue virus sequences and methods of use |
| 01/30/2013 | CN102899336A Preparation method and application of Coxsackie virus B3 virus-like particles |
| 01/30/2013 | CN102899295A Duck hemorrhagic ovaritis virus |
| 01/30/2013 | CN102899294A Vaccine strain of HIN1 swine influenza virus and application thereof |
| 01/30/2013 | CN101979515B Animal rabies virus and vaccine and production method thereof |
| 01/30/2013 | CN101056977B Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection |
| 01/29/2013 | US8361978 Use of herpes vectors for tumor therapy |
| 01/29/2013 | US8361776 Adaptation of Pitman Moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 01/29/2013 | US8361775 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 01/29/2013 | US8361457 Duplexed parvovirus vectors |
| 01/29/2013 | CA2560487C Optimized expression of hpv 52 l1 in yeast |
| 01/29/2013 | CA2522081C Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/29/2013 | CA2467099C Method for the recovery and purification of poxviruses from infected cells |
| 01/29/2013 | CA2342849C Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/29/2013 | CA2322160C Vaccines, immunotherapeutics and methods for using the same |
| 01/29/2013 | CA2258485C Ribonuclease resistant rna preparation and utilization |
| 01/24/2013 | WO2013013118A1 Method to increase the infectivity of virus particles |
| 01/24/2013 | WO2013011942A1 Mutant canine madness virus and vaccine |
| 01/24/2013 | WO2013010797A1 Process for producing viral antigen and vaccines |
| 01/24/2013 | WO2012157989A3 Avirulent modified salmonella gallinarum strains and pharmaceutical composition using the same |
| 01/24/2013 | US20130023034 Mutated rep encoding sequences for use in aav production |
| 01/24/2013 | US20130023033 Pharmacologically induced transgene ablation system |
| 01/24/2013 | US20130023032 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof |
| 01/24/2013 | US20130023031 Pseudoinfectious Flavivirus and Uses Thereof |
| 01/24/2013 | US20130023030 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 01/24/2013 | US20130022961 Assay for jc virus antibodies |
| 01/24/2013 | US20130022637 Recombinant baculovirus vaccine |
| 01/24/2013 | US20130022631 Vaccine for chikungunya virus infection |
| 01/24/2013 | US20130022602 Methods and compositions to modulate antiviral and immune activity responses |
| 01/24/2013 | US20130022579 Bacteriophage and antibacterial composition comprising the same |
| 01/24/2013 | CA2841604A1 Process for producing viral antigen and vaccines |
| 01/23/2013 | EP2547770A2 Live attenuated chimeric porcine circovirus vaccine |
| 01/23/2013 | CN102892878A Cell culture medium comprising small peptides |
| 01/23/2013 | CN102892424A Stabilisation of viral particles |
| 01/23/2013 | CN102888413A Hcv基因 Hcv gene |
| 01/23/2013 | CN102888383A Recombinant porcine pseudorabies virus TK/gE double-gene deletion strain |
| 01/23/2013 | CN102887951A Tuberculosis peptide Ag85B199-207 specific TCR and recombinant retroviral vector and use thereof |
| 01/23/2013 | CN102465117B Chimeric simian/human immunodeficency virus strain and application thereof |
| 01/23/2013 | CN102286534B Insect bioreactor capable of expressing multiple exogenous genes, and construction method and application thereof |
| 01/23/2013 | CN102277335B Chinese Baoding isolate of sugarcane mosaic virus and complete sequence of genome thereof |
| 01/23/2013 | CN102181407B Recombinant adenovirus and dendritic cell modified by recombinant adenovirus and application of recombinant adenovirus and dendritic cell |
| 01/23/2013 | CN102115729B Method for culturing baby hamster kidney (BHK) 21 cell in serum-free way, and vaccine preparation method |
| 01/23/2013 | CN102100910B Method for producing viral vaccines |
| 01/23/2013 | CN101228267B Cell line for producing coronaviruses |
| 01/22/2013 | US8357525 Thermal inactivation of rotavirus |
| 01/22/2013 | CA2622074C Rapid production of high titer virus |
| 01/22/2013 | CA2536735C Methods for determining cd8+ t-cell epitopes |
| 01/22/2013 | CA2513458C Virulent systemic feline calicivirus |
| 01/22/2013 | CA2441663C Viral vectors and their use in therapeutic methods |
| 01/17/2013 | US20130017575 Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity |
| 01/17/2013 | US20130017224 Nucleic Acid Molecules Encoding Rantes, and Compositions Comprising and Methods of Using the Same |
| 01/16/2013 | EP2545165A2 Mutated rep encoding sequences for use in aav production |
| 01/16/2013 | CN102876714A Method for detecting HIV (Human Immunodeficiency Virus) drug resistant phenotype with lentiviruses |
| 01/16/2013 | CN102876707A Preparation method of recombinant poliovirus I-type virus-like particles |
| 01/16/2013 | CN102876688A Method for preparing recombinant polio I virus-like particles |
| 01/16/2013 | CN102876638A Recombinant influenza virus capable of realizing high-efficiency expression of HA protein, and preparation method and application of recombinant influenza virus |
| 01/16/2013 | CN102086447B Duck virus hepatitis strains and inactivated vaccine |
| 01/16/2013 | CN101024845B Use of nucleotide sequence for encoding protein of gag and pol, method for producing replication-defective retrovirus |
| 01/15/2013 | US8354518 HCV replicons containing NS5B from genotype 2B |
| 01/15/2013 | CA2461710C Incapacitated whole-cell immunogenic bacterial compositions |
| 01/15/2013 | CA2460269C Alphavirus replicon vector systems |
| 01/15/2013 | CA2451864C Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/15/2013 | CA2323011C Method for the development of an hiv vaccine |
| 01/10/2013 | WO2013006815A1 Methods and compositions to modulate antiviral and immune activity responses |
| 01/10/2013 | WO2013004817A1 Genetically modified phage and use thereof |
| 01/10/2013 | WO2013004396A2 Adeno-parvovirus chimera with enhanced oncolytical potential |
| 01/10/2013 | US20130012429 Anti-viral therapy |
| 01/10/2013 | US20130011898 Genetically Modified Phage and Use Thereof |
| 01/10/2013 | US20130011435 Composition for treating hbv infection |
| 01/10/2013 | US20130011433 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011369 Method for Prevention and Treatment of Salmonella Infection |
| 01/10/2013 | CA2841805A1 Genetically modified phage and use thereof |
| 01/10/2013 | CA2832369A1 Adeno-parvovirus chimera with enhanced oncolytical potential |
| 01/09/2013 | EP2543734A1 Adeno-parvovirus chimera with enhanced oncolytical potential |
| 01/09/2013 | EP2543720A1 Genetically modified phage and use thereof |
| 01/09/2013 | EP2542681A2 Protein and nucleic acid delivery vehicles, components and mechanisms thereof |
| 01/09/2013 | EP2542260A1 Recombinant attenuated parvovirus |
| 01/09/2013 | CN102864130A Recombination influenza virus for high-efficiency expression HA (hemagglutinin) protein and preparation method and application thereof |
| 01/09/2013 | CN102864129A Recombinant influenza virus for efficiently expressing HA (Hemagglutinin) protein and preparation method as well as application thereof |
| 01/09/2013 | CN102864128A Recombinant influenza virus for efficiently expressing HA protein, and preparation method and application thereof |
| 01/09/2013 | CN102864127A Recombinant influenza virus for efficiently expressing HA (Hemagglutinin) protein and preparation method as well as application thereof |
| 01/09/2013 | CN102864126A Recombinant virus of standard attack strain CVS-11 and preparation method thereof |
| 01/09/2013 | CN102861327A Cell inactivated vaccine, egg yoke antibody and injection and freeze-dried powder containing same |
| 01/09/2013 | CN101948811B Method for expanding antigen spectrum of foot-and-mouth disease vaccine strain by reverse genetic operation and preparation method of vaccine |
| 01/09/2013 | CN101194165B Method for porcine circovirus production and assays for monitoring production |
| 01/08/2013 | US8349606 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 01/08/2013 | US8349582 High-efficiency viable sampler for ultrafine bioaerosols |
| 01/08/2013 | CA2604824C Retroviral packaging cell line |
| 01/08/2013 | CA2457441C Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use |
| 01/08/2013 | CA2409873C Hcv variants |
| 01/08/2013 | CA2388337C Method of inducing and/or enhancing an immune response to tumor antigens |
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/08/2013 | CA2216139C Recombinant infectious laryngotracheitis virus and uses thereof |
| 01/03/2013 | WO2013002449A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | WO2013001285A2 Peptide |
| 01/03/2013 | WO2013001034A1 Novel stabilisation method for viruses or bacteria |
| 01/03/2013 | WO2013000905A1 Canine coronavirus vaccine |
| 01/03/2013 | WO2012151391A3 Inactivated swine flu virus and methods of preparing it |